What is Bioseal?
Bioseal Inc. has been a trusted provider of surgical supplies for over 35 years, specializing in essential products for hospitals. Their offerings encompass surgical put-ups, single-use instruments, and infection control solutions, including the Duraholder Instrument Protection System, BioView Scopes, and custom procedural trays. The company targets healthcare professionals such as sterile processing managers, operating room managers, and infection control specialists, emphasizing quality management and custom manufacturing to meet diverse client needs across the country.
How much funding has Bioseal raised?
Bioseal has raised a total of $1.3M across 2 funding rounds:
Debt
$350K
Debt
$926K
Debt (2020): $350K with participation from PPP
Debt (2021): $926K led by PPP
What's next for Bioseal?
The recent major strategic investment, alongside the overall enterprise-level financing, suggests Bioseal is poised for continued operational enhancement and market penetration. This capital will likely support the expansion of their product lines, further solidify their relationships with healthcare institutions, and potentially drive innovation in surgical supply and infection control technologies. The company's sustained presence and focus on quality indicate a strategic path toward reinforcing its role as a key partner for hospitals seeking reliable and specialized medical supplies.
See full Bioseal company page
